For example, in GC, the expression levels of genes related to ferroptosis, such as ferroptosis suppressor protein 1 and CDGSH iron–sulfur domain 1, which are biomarkers of poor prognosis for patients with GC, are extremely high; these genes are promising therapeutic targets for future GC treatment [94]. This evidence concerns the gene AIFM2 and gastric cancer.